Form 4: Innoviva Director Receives Stock Options and RSUs

Innoviva, Inc. reports that Director Sarah J. Schlesinger was granted stock options and restricted stock units following the 2026 annual meeting.

Summary

• Director Sarah J. Schlesinger received a grant of non-statutory stock options and restricted stock units (RSUs) on May 4, 2026.
• The grant was made upon the conclusion of the Issuer's 2026 annual meeting of stockholders.
• 100% of the RSUs and Options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of the grant date.
• Vesting is contingent upon the Reporting Person's continuous service as an Outside Director through the applicable vesting date.
• Accelerated vesting is provided in the event of the Reporting Person's death, disability, or a "change in control" of the Issuer, subject to certain conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation grant to a director rather than a significant financial event or strategic shift for the company.

Positives

• Director compensation through stock options and RSUs aligns management and director interests with shareholders.
• Vesting schedule tied to continued service and specific corporate events incentivizes long-term commitment and performance.
• Accelerated vesting provisions for death, disability, or change in control offer security to the director.

Negatives

• The filing does not provide details on the number of RSUs granted, only the number of stock options (10,000).
• The exercise price for the stock options is $22.99, which may be above the current market price if the stock has declined.

Risks

• Vesting is subject to continuous service, meaning a departure before vesting would result in forfeiture of the unvested portion.
• The definition of "change in control" in the 2026 Equity Incentive Plan could lead to complex scenarios for accelerated vesting.
• Market volatility could impact the value of the stock options and RSUs if the stock price does not appreciate.

Future Outlook

Vesting of the granted RSUs and stock options is tied to future events, including the next annual stockholder meeting, the one-year anniversary of the grant, or specific trigger events like death, disability, or a change in control.

Management Comments

• The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon the conclusion of the Issuer's 2026 annual meeting of stockholders.
• 100% of the RSUs and Options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such "change in control," death or disability.

Industry Context

StockSavvy.ai notes that the granting of stock options and RSUs to directors is a common practice in the pharmaceutical and biotechnology sectors, including companies like Innoviva, Inc., to attract and retain experienced leadership and align their financial interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The grant aligns director incentives with shareholder interests, potentially leading to decisions that enhance shareholder value. However, the dilutive effect of equity grants should be considered.
• Employees: Standard compensation practice for directors, unlikely to have a direct impact on employees.
• Creditors: No direct impact.
• Suppliers/Customers: No direct impact.

Next Steps

• Director Schlesinger must maintain continuous service as an Outside Director through the vesting dates for the RSUs and stock options to vest.
• The RSUs and stock options will vest on the next annual stockholder meeting or the one-year anniversary of the grant, whichever comes first.
• Vesting may accelerate upon death, disability, or a change in control event.

Key Dates

Keywords

Innoviva Inc, INVA, Form 4, SEC Filing, Stock Options, Restricted Stock Units, RSUs, Director Compensation, Beneficial Ownership, Insider Trading, Equity Incentive Plan, Vesting Schedule, Change in Control